Teva Pharmaceutical Industries Limited (TEVA) News Headlines

▮ More

Date

Headline

7/15/2019 8:57:54 AM Teva Pharma Announces FDA Approval Of AirDuo Digihaler - Quick Facts

7/15/2019 8:36:53 AM Teva Announces FDA Approval Of AirDuo Digihaler Inhalation Powder

7/2/2019 2:34:23 AM Teva To Present FOCUS Exploratory Endpoints Results

7/1/2019 8:41:18 AM Teva Announces Launch Of 1% Sodium Hyaluronate In The U.S.

5/28/2019 2:35:07 PM Teva Stock Downgraded To Neutral By UBS, Stock Down 12%

5/2/2019 7:14:48 AM Teva Pharmaceutical Industries Limited Q1 adjusted earnings Beat Estimates

5/2/2019 7:04:58 AM Teva Q1 Non-GAAP EPS $0.60; GAAP Loss Per Share $0.10

5/2/2019 7:00:17 AM Teva Pharmaceutical Q1 19 Earnings Conference Call At 8:00 AM ET

4/23/2019 9:19:37 AM Teva To Discontinue Fremanezumab Development Program - Quick Facts

4/23/2019 9:09:48 AM Compass Minerals Names Kevin Crutchfield President And CEO

4/23/2019 9:07:54 AM Teva Discontinues Clinical Development Program For Use Of Fremanezumab In Cluster Headaches

4/10/2019 8:11:36 AM Teva Enters New $2.3 Bln Unsecured Revolving Credit Facility

4/1/2019 8:30:39 AM Teva: AJOVY Gets EU Approval Offering Patients First, Only Anti-CGRP Treatment

3/18/2019 7:25:53 AM Novo Nordisk, Teva Settle US Patent Litigation For Victoza - Quick Facts

3/18/2019 7:05:34 AM Novo Nordisk Settles US Patent Litigation Case On Victoza With Teva

2/13/2019 7:47:06 AM Teva Shares Fall As Q4 Adj. Profit Misses View, Outlook Disappoints

2/13/2019 7:09:53 AM Teva Pharmaceutical Industries Limited Q4 adjusted earnings of $0.53 per share

2/13/2019 7:04:29 AM Teva Q4 Non-GAAP EPS $0.53, GAAP Loss Per Share $2.85

2/13/2019 7:03:34 AM Teva Pharmaceutical Q4 18 Earnings Conference Call At 8:00 AM ET

2/6/2019 11:26:15 AM Teva Announces U.S. Launch Of A Generic Version Of Sabril